Search results (10)
« Back to PublicationsMAIT and other innate-like T cells integrate adaptive immune responses to modulate interval-dependent reactogenicity to mRNA vaccines
Journal article
Amini A. et al, (2025), Science Immunology, 10
Dosing interval is a major factor determining the quality of T cells induced by SARS-CoV-2 mRNA and adenoviral vector vaccines
Journal article
Murray SM. et al, (2025), Science Immunology, 10
Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients
Journal article
Murray SM. et al, (2024), Journal of Hepatology, 80, 109 - 123
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
Journal article
Murray SM. et al, (2023), Nature Reviews Immunology, 23, 304 - 316
Impaired humoral and cellular response to primary COVID‐19 vaccination in patients less than 2 years after allogeneic bone marrow transplant
Journal article
Murray SM. et al, (2022), British Journal of Haematology, 198, 668 - 679
Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy.
Journal article
Pinato DJ. et al, (2021), Journal for immunotherapy of cancer, 9
Immunotherapy in Hepatocellular Carcinoma.
Journal article
Fulgenzi CAM. et al, (2021), Current treatment options in oncology, 22
Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2.
Journal article
McDonald I. et al, (2021), NPJ vaccines, 6
Chlamydia trachomatis: Cell biology, immunology and vaccination.
Journal article
Murray SM. and McKay PF., (2021), Vaccine, 39, 2965 - 2975
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection.
Journal article
Reynolds CJ. et al, (2020), Science immunology, 5